About Careers MedBlog Contact us

A New Pack For Lung Cancer Treatment

by Medindia Content Team on June 13, 2006 at 12:41 PM
Font : A-A+

A New Pack For Lung Cancer Treatment

Thousands of patients hope came true, YES! A new treatment for lung cancer was approved for use in Scotland .

A drug named Tarceva, was the new one which significantly increases the survival rates of cancer patients.


When taken as a pill, the drug approved by the Scottish Medicines Consortium (one per day), reduces the pressure on chemotherapy - Specialists and cancer support groups exclaimed that it benefits about 1500 patients every year.

A lung cancer patient in the advanced non-small cell stage, takes the drug which cost about 1700 a month per patient and needs to be given to people who have failed to respond to chemotherapy.

Chemotherapy proves to increase the survival rate by about 20%, whereas in the last year the rate was only 10% - said Dr Nicolson. But sometimes people won't fit with chemotherapy due to relapses after treatment.

Dr Nicolson added the new treatment with Tarceva had lesser side effects like hair loss, pain, cough, breathless, and even better quality of life than in chemotherapy.

Scottish lung cancer rates are the worst in the UK and around 4500 new cases are diagnosed each year north of the border.

Need for the drug in UK is more because around 4500 new cases were diagnosed each year. The National Institute of Clinical Excellence (Nice) has not yet permitted the use of Tarceva, whose pharmaceutical name is erlotinib, in England and Wales.



Recommended Reading

Latest Cancer News

Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
How Does New Drugs Work Together to Reduce Lung Tumors?
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
New Combination Therapy Proves Effective Against Prostate Cancer
Combination treatment with TALZENNA and XTANDI was found to benefit prostate cancer patients, revealed study.
Can Vitamin A Rich Diet Help Reduce Pancreatitis Risk
In leukemia patients, reduced amounts of dietary vitamin A is associated with a higher risk and severity of pancreatitis.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

A New Pack For Lung Cancer Treatment Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests